ArticleBJUI compass2025
Development of a prediction model for urinary tract infection risk after open reimplantation in children with primary unilateral vesicoureteral reflux: A multicentre study.
Article in BJUI compass, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To develop a predictive model for symptomatic postoperative febrile urinary tract infections (UTIs) in children undergoing open reimplantation for vesicoureteral reflux (VUR) and evaluate the association with VUR recurrence. Patients and methods: This multicentre retrospective study included children with unilateral VUR (grades III-V) who underwent open Cohen or Lich-Gregoir reimplantation (2010-2022), had recurrent febrile UTIs, and ≥1 year follow-up. Analyses used 10-pooled multiple imputation, with complete case for sensitivity. Full and Least Absolute Shrinkage and Selection Operator (LASSO) Weibull regression models with centre clustering, bootstrapping, and 10-fold cross-validation identified predictors. Prediction used demographic, clinical, procedural and antibiotic factors. The non-scaled LASSO model informed the nomogram, evaluated using C-indices, calibration and decision curve analysis (DCA). UTI and VUR recurrence were analysed via cumulative incidence. Results: A total of 404 children (median age 8 (6-9) years; follow-up 2.3 (2.0-3.3) years, 233 complete-case) were analysed. Median preoperative febrile UTIs were four, 74.5% had antibiotic resistance and median postoperative prophylaxis was two days. The 3-year cumulative incidence of postoperative UTI was 27.2% (95% CI: 22.9-31.6). LASSO-significant predictors included operative time (HR 1.10, 95% CI 1.03-1.16); in sensitivity analyses, prior injection (HR 2.08, 95% CI 1.88-2.30) and postoperative antibiotic duration (HR 0.81, 95% CI 0.69-0.97) were also significant. The nomogram included preoperative fever, antibiogram resistance, renal defect, VUR phase, prior injection, surgical indication, catheterization, hospitalization and stenting. The model performed well (C-indices = 0.743; calibration slope = 1), with DCA supporting clinical utility for 10-40% predicted risk. Recurrent VUR grade ≥II after 12 months (3.3%-12.7% at 1-3 years, n = 273) did not increase UTI risk. Conclusions: Children with unilateral dilating VUR remained at risk of postoperative febrile UTIs. The nomogram can assist in identifying high-risk children for targeted interventions, but requires external validation and refinement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.